TFEB and renal cell carcinoma: Translocation RCC tumors were historically diagnosed with IHC staining for TFE3 or TFEB antibodies; however, recent shifts towards the use of fluorescence in situ hybridization (FISH) may help reduce the incidence of false positive or negative results to more accurately identify tRCC [84,85].